BR9709529A - Fragmentos de leptina (proteína ob) - Google Patents

Fragmentos de leptina (proteína ob)

Info

Publication number: BR9709529A
Authority: BR; Brazil
Prior art keywords: protein; leptin fragments; leptin; fragments
Prior art date: 1996-06-06

Application number

BR9709529A

Other languages

English (en)

Portuguese (pt)

Inventor

Kamal A Al-Barazanji

Jonathan Robert Sanders Arch

Patrick Camilleri

William Arthur Neville

Original Assignee

Smithkline Beecham P L C Socie

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-06

Filing date

1997-06-04

Publication date

1999-08-10

1996-06-06 Priority claimed from GBGB9611775.9A external-priority patent/GB9611775D0/en

1996-09-05 Priority claimed from GBGB9618540.0A external-priority patent/GB9618540D0/en

1997-02-20 Priority claimed from GBGB9703493.8A external-priority patent/GB9703493D0/en

1997-06-04 Application filed by Smithkline Beecham P L C Socie filed Critical Smithkline Beecham P L C Socie

1999-08-10 Publication of BR9709529A publication Critical patent/BR9709529A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
General Chemical & Material Sciences (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Child & Adolescent Psychology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BR9709529A 1996-06-06 1997-06-04 Fragmentos de leptina (proteína ob) BR9709529A (pt)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GBGB9611775.9A GB9611775D0 (en)	1996-06-06	1996-06-06	Novel compounds
GBGB9618540.0A GB9618540D0 (en)	1996-09-05	1996-09-05	Novel compounds
GBGB9703493.8A GB9703493D0 (en)	1997-02-20	1997-02-20	Novel compounds
PCT/EP1997/002968 WO1997046585A2 (en)	1996-06-06	1997-06-04	Fragments of leptin (ob protein)

Publications (1)

Publication Number	Publication Date
BR9709529A true BR9709529A (pt)	1999-08-10

Family

ID=27268305

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9709529A BR9709529A (pt)	1996-06-06	1997-06-04	Fragmentos de leptina (proteína ob)

Country Status (15)

Country	Link
EP (1)	EP0912609A2 (cs)
JP (1)	JP2000512137A (cs)
KR (1)	KR20000016402A (cs)
CN (1)	CN1221426A (cs)
AR (1)	AR008765A1 (cs)
AU (1)	AU3337297A (cs)
BR (1)	BR9709529A (cs)
CA (1)	CA2257240A1 (cs)
CZ (1)	CZ397898A3 (cs)
IL (1)	IL127153A0 (cs)
NO (1)	NO985683D0 (cs)
NZ (1)	NZ332879A (cs)
PL (1)	PL330361A1 (cs)
TR (1)	TR199802534T2 (cs)
WO (1)	WO1997046585A2 (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6001968A (en)	1994-08-17	1999-12-14	The Rockefeller University	OB polypeptides, modified forms and compositions
EP1101112B1 (en)	1998-07-28	2004-10-06	Vlaams Interuniversitair Instituut voor Biotechnologie vzw.	Leptin-mediated gene-induction
US7208572B2 (en)	1998-08-21	2007-04-24	Albany Medical College	Leptin-related peptides
US6777388B1 (en)	1998-08-21	2004-08-17	Clf Medical Technology Acceleration Program, Inc.	Leptin-related peptides
US6420339B1 (en)	1998-10-14	2002-07-16	Amgen Inc.	Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
CA2388417A1 (en)	1999-09-22	2001-03-29	Genset	Methods of screening for compounds that modulate the lsr-leptin interaction and their use in the prevention and treatment of obesity-related diseases
AU8178401A (en)	2000-05-22	2001-12-03	Vlaams Interuniv Inst Biotech	Receptor-based interaction trap
DK2219031T3 (da)	2001-10-22	2013-06-17	Amgen Inc	Anvendelse af leptin til behandling af human lipoatrofi og fremgangsmåde til bestemmelse af prædisposition for behandlinngen
ES2300817T3 (es)	2003-09-08	2008-06-16	Laboratoires Serono Sa	Tratamiento de enfermedades fibroticas.
IN2012DN03921A (cs)	2004-02-11	2015-09-04	Amylin Pharmaceuticals Inc
US7575878B2 (en)	2004-11-18	2009-08-18	Vib Vzw	Methods of inhibiting leptin-induced signaling with fibronectin III domain antibodies
WO2007022123A2 (en)	2005-08-11	2007-02-22	Amylin Pharmaceuticals, Inc.	Hybrid polypeptides with selectable properties
EA011653B1 (ru)	2005-02-11	2009-04-28	Амилин Фармасьютикалз, Инк.	Аналоги и гибридные полипептиды gip с избираемыми свойствами
US7629315B2 (en)	2005-03-09	2009-12-08	University Of Pittsburgh Of The Commonwealth System Of Higher Education	Compositions for blocking the inhibitory effect of human CRP on human leptin
EP2330125A3 (en)	2005-08-11	2012-12-12	Amylin Pharmaceuticals, Inc.	Hybrid polypeptides with selectable properties
ES2319048B1 (es) *	2007-06-20	2010-02-10	Universitat De Les Illes Balears	Uso de leptina en el tratamiento de alteraciones en los habitos alimentarios.
US8889622B2 (en)	2007-07-25	2014-11-18	Washington University	Methods of inhibiting seizure in a subject
GB2451858A (en) *	2007-08-15	2009-02-18	Sergiy Konovchuk	Methods of reducing body fat and treating obesity
EP2229362A1 (en)	2007-12-05	2010-09-22	AstraZeneca AB	Piperazines as anti-obesity agents
CA2707248A1 (en)	2007-12-05	2009-06-11	Astrazeneca Ab	New compounds ii
CA2726441A1 (en) *	2008-06-04	2009-12-10	Michael Higginbottom	New pyridine derivatives as leptin receptor modulator mimetics
WO2009147211A1 (en) *	2008-06-04	2009-12-10	Biovitrum Ab (Publ)	New compounds v
WO2010118384A2 (en)	2009-04-10	2010-10-14	Amylin Pharmaceuticals, Inc.	Amylin agonist compounds for estrogen-deficient mammals
EP2569326B1 (en) *	2010-05-11	2016-08-10	The U.S.A. as represented by the Secretary, Department of Health and Human Services	Peptide-based inhibitor of interleukin-10 or stat-3 activation
CA3138758A1 (en)	2010-09-28	2012-04-19	Amylin Pharmaceuticals, Llc	Highly soluble leptins
CN104829707B (zh) *	2015-05-06	2017-12-19	广东省生物资源应用研究所	一条cd环和e螺旋区突变的瘦素活性肽及其编码基因和应用
CN110183530A (zh) *	2019-06-21	2019-08-30	深圳市亚辉龙生物科技股份有限公司	瘦素免疫原、杂交瘤细胞、单克隆抗体、多克隆抗体及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6309853B1 (en) *	1994-08-17	2001-10-30	The Rockfeller University	Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
US5552523A (en) *	1995-01-31	1996-09-03	Eli Lilly And Company	Anti-obesity proteins
JPH11501297A (ja) *	1995-01-31	1999-02-02	イーライ・リリー・アンド・カンパニー	抗肥満症タンパク質
AU4766596A (en) *	1995-01-31	1996-08-21	Eli Lilly And Company	Ob gene product antibodies
WO1996031526A1 (en) *	1995-04-06	1996-10-10	Amylin Pharmaceuticals, Inc.	Anti-obesity agents
GB9509164D0 (en) *	1995-05-05	1995-06-28	Smithkline Beecham Plc	Novel compounds

1997
- 1997-06-04 TR TR1998/02534T patent/TR199802534T2/xx unknown
- 1997-06-04 CN CN97195311A patent/CN1221426A/zh active Pending
- 1997-06-04 WO PCT/EP1997/002968 patent/WO1997046585A2/en not_active Application Discontinuation
- 1997-06-04 CA CA002257240A patent/CA2257240A1/en not_active Abandoned
- 1997-06-04 AR ARP970102432A patent/AR008765A1/es unknown
- 1997-06-04 IL IL12715397A patent/IL127153A0/xx unknown
- 1997-06-04 CZ CZ983978A patent/CZ397898A3/cs unknown
- 1997-06-04 EP EP97929156A patent/EP0912609A2/en not_active Withdrawn
- 1997-06-04 KR KR1019980709976A patent/KR20000016402A/ko not_active Application Discontinuation
- 1997-06-04 NZ NZ332879A patent/NZ332879A/xx not_active IP Right Cessation
- 1997-06-04 JP JP10500240A patent/JP2000512137A/ja active Pending
- 1997-06-04 PL PL97330361A patent/PL330361A1/xx unknown
- 1997-06-04 AU AU33372/97A patent/AU3337297A/en not_active Abandoned
- 1997-06-04 BR BR9709529A patent/BR9709529A/pt not_active Application Discontinuation
1998
- 1998-12-04 NO NO985683A patent/NO985683D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CZ397898A3 (cs)	1999-04-14
CA2257240A1 (en)	1997-12-11
NZ332879A (en)	2000-09-29
WO1997046585A2 (en)	1997-12-11
NO985683L (no)	1998-12-04
IL127153A0 (en)	1999-09-22
PL330361A1 (en)	1999-05-10
JP2000512137A (ja)	2000-09-19
WO1997046585A3 (en)	1998-04-23
TR199802534T2 (xx)	1999-03-22
CN1221426A (zh)	1999-06-30
EP0912609A2 (en)	1999-05-06
AR008765A1 (es)	2000-02-23
NO985683D0 (no)	1998-12-04
AU3337297A (en)	1998-01-05
KR20000016402A (ko)	2000-03-25

Publication	Publication Date	Title
BR9709529A (pt)	1999-08-10	Fragmentos de leptina (proteína ob)
DE69724557D1 (de)	2003-10-09	Dokumentenanalyse
DE69722620D1 (de)	2003-07-10	Nicht-waessrige protische peptidzubereitungen
NO985680L (no)	1999-02-04	Peptidderivater
NO983849L (no)	1998-10-21	Peptidderivater
BR9610239A (pt)	1999-06-15	Proteínas de fusão-alérgeno-xcd32
DE59707298D1 (de)	2002-06-20	Desodorierende zubereitungen
GB9614033D0 (en)	1996-09-04	Modified protein G and fragments thereof
TR199701666A3 (tr)	1999-10-21	Sismanliga karsi proteinler
DE69925271D1 (de)	2005-06-16	Angiostatin-bindendes protein
DE69718328D1 (de)	2003-02-13	Magnetrongerät
FR2865535B1 (fr)	2006-06-23	Penetreur
DE59602924D1 (de)	1999-10-07	Knochenraspel
DE59702387D1 (de)	2000-10-26	Medizinische zange
KR970004260U (ko)	1997-02-19	정형외과용 콜셋
BR7601137U (pt)	1998-07-14	Bone
AU2003204475A1 (en)	2003-06-26	Fragments of leptin (ob protein)
GB9604865D0 (en)	1996-05-08	Modified proteins
KR970059003U (ko)	1997-11-10	조인트용 부트
KR970064121U (ko)	1997-12-11	마그네트론
SE9602287D0 (sv)	1996-06-10	Novel protein and methods for its use
SE9601761D0 (sv)	1996-05-08	T-ventilförfarande
ID16704A (id)	1997-11-06	Metoda penyembuhan
KR970060687U (ko)	1997-12-10	콘돔(Condom)
UA1372S (uk)	1997-02-28	Цвях

Legal Events

Date	Code	Title	Description
2006-12-12	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2007-04-27	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.PORTANTO, INDEFIRO O PRESENTE PEDIDO.